First Time Loading...

Global Blood Therapeutics Inc
NASDAQ:GBT

Watchlist Manager
Global Blood Therapeutics Inc Logo
Global Blood Therapeutics Inc
NASDAQ:GBT
Watchlist
Price: 68.49 USD Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

GBT Price Targets Summary
Global Blood Therapeutics Inc

There are no price targets for GBT.
GBT Lowest Forecast
Wall Street Target
Not Available
GBT Average Forecast
Wall Street Target
Not Available
GBT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Global Blood Therapeutics Inc Competitors:
Price Targets
XNCR
Xencor Inc
52% Upside
ZEAL
Zealand Pharma A/S
23% Upside
OCX
OncoCyte Corp
50% Upside
BONEX
Bonesupport Holding AB
33% Upside
XNCR
Xencor Inc
52% Upside
ZEAL
Zealand Pharma A/S
23% Upside
OCX
OncoCyte Corp
50% Upside
BONEX
Bonesupport Holding AB
33% Upside
LEGN
Legend Biotech Corp
94% Upside
BNTX
BioNTech SE
32% Upside
3164
GenMont Biotech Inc
349% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Global Blood Therapeutics Inc

The compound annual growth rate of Global Blood Therapeutics Inc's revenue for the next 2 years is 53%.

N/A
Past Growth
53%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Global Blood Therapeutics Inc

Operating Income forecast
is not available for
Global Blood Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Global Blood Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

See Also

Summary
GBT intrinsic value, competitors valuation, and company profile.
DCF Valuation
GBT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GBT stock valuation using valuation multiples.
Wall Street Estimates
GBT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GBT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GBT's stock price target?
Not Available

GBT doesn't have any price targets made by Wall Street professionals.

What is Global Blood Therapeutics Inc's Revenue forecast?
Projected CAGR
53%

The compound annual growth rate of Global Blood Therapeutics Inc's revenue for the next 2 years is 53%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.